Yoon et al. (2016) have reported that stromal p16INK4a expression is significantly increased in BOTs compared to benign lesions (p < 0.001) and in malignant tumours compared to BOTs (p < 0.001) [78]. This evidence concerns the gene CDKN2A and cancer.